AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

89,900

Employees89,900

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1992

Founded1992

Employees

89,900

Employees89,900

AZN Key Statistics

Market cap

206.73B

Market cap206.73B

Price-Earnings ratio

31.94

Price-Earnings ratio31.94

Dividend yield

2.17%

Dividend yield2.17%

Average volume

5.45M

Average volume5.45M

High today

$66.79

High today$66.79

Low today

$66.15

Low today$66.15

Open price

$66.60

Open price$66.60

Volume

6.54M

Volume6.54M

52 Week high

$87.68

52 Week high$87.68

52 Week low

$60.47

52 Week low$60.47

AZN News

Benzinga 2d

AstraZeneca-Merck Partnered Lynparza Shows Long-Term Survival With Reduced Death Risk Of 28% In Breast Cancer Patients

AstraZeneca Plc AZN and Merck & Co Inc MRK, on Wednesday, announced long-term results from the OlympiA Phase 3 trial. The trial showed Lynparza (olaparib) demo...

Seeking Alpha 2d

AstraZeneca, Merck report positive long-term data for Lynparza

AstraZeneca (NASDAQ:AZN) and Merck (NYSE:MRK) said long-term data from a Phase 3 study showed that 87.5% of patients treated with their breast cancer drug Lynpa...

TipRanks 5d

AstraZeneca reports ‘positive’ results from AMPLIFY Phase 3 trial

“Positive” results from the AMPLIFY Phase III trial showed AstraZeneca’s (AZN) Calquence in combination with venetoclax demonstrated a statistically significant...

Analyst ratings

81%

of 32 ratings

Buy

81.3%

Hold

18.8%

Sell